Health Trials

Solid Advanced Tumor

2

Review clinical trials related to Solid Advanced Tumor. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

This is a phase 1/2, multicenter, dose-finding and dose expansion study of OSE-279, a PD-1 blocking monoclonal antibody, in subjects with advanced solid tumors or lymphomas.

Participants needed: 41
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: OSE ImmunotherapeuticsUpdated: Jun 4, 2026Locations: 11
Eligibility criteria

Signed and dated informed consent form (ICF) prior to any trialspecific procedur... [+19]

Read more
Status: Recruiting

Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.

This is a multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of the anti-EGFR/c-Met bispecific antibody MCLA-129 in combination with Ensartinib hydrochloride in patients with advanced solid tumors.

Participants needed: 164
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Betta Pharmaceuticals Co., Ltd.Updated: Mar 4, 2026Locations: 1
Eligibility criteria

Subjects should be aged 18-75 years (both inclusive), regardless of gender. [+9]

Subjects with non-small cell lung cancer who have been tested positive for ALK i... [+16]

Read more